Nov 5, 2026

Acumen Pharmaceuticals, Inc. layoff.

AI: Unclear

8-K Item 2.05 filed 2026-11-05: In connection with these decisions, on November 1, 2026, the board of directors of the Company (the “Board”) approved certain steps to implement cash conservation measures, including a reduction of the Company’s workforce by 52 full-time em

Affected

52

Share of workforce

—

Announced

Nov 5, 2026

The count

For the people in it

The day after.

Your rights in this state

The federal WARN Act covers employers with 100 or more full-time workers. It requires 60 days' written notice before a plant closing that affects 50 or more workers at one site, or a mass layoff of 500 or more workers (or 50 to 499 when that is at least a third of the site).

Federal WARN (100+ employees, 60 days' notice) is the only rule we can confirm for this state.

This is an editorial summary, not legal advice.

WARN filed
—
Notice date
—
Separation date
—
Notice given
—

The package, as reported

Severance base
—
Per year of service
—
Benefits continued
—
Equity
—
Outplacement
—

How it was done

Delivery
—
Timing
—
Roles affected
—

If you were in this cohort.

  1. 01

    File for unemployment the week you're separated — not when the severance runs out.

  2. 02

    Check your notice date against the 60-day federal WARN rule.

  3. 03

    Find out whether your COBRA window starts when benefits end or on your separation date.

Read The First 72 Hours →

Pack Finder

No public room for Acumen Pharmaceuticals, Inc. yet.

A Job Search Council is always open: four to six peers at your career stage, free and volunteer-run.

Evidence

  • SEC filing · Form 8-K · Nov 5, 2026 · SEC accession 0001628280-26-070987

    “In connection with these decisions, on November 1, 2026, the board of directors of the Company (the “Board”) approved certain steps to implement cash conservation measures, including a reduction of the Company’s workforce by 52 full-time employees, or approximately 90% of the Company’s current employee base (the “Restructuring”). The Company initiated the Restructuring on November 2, 2026, with the majority of impacted positions ending in November 2026 and a small number of positions maintained into early 2027. As a result of the Restructuring, the Company estimates that it will incur approximately $7.75 million in costs resulting from cash expenditures consisting of one-time severance payme”
    SEC Form 8-K, Item 2.05 ↗

Sources for this event: sec_8k, SEC Form 8-K, Item 2.05. All Acumen Pharmaceuticals, Inc. records · Report a correction

Cite this

According to Tracked by PinkSlipped, …

Source: Tracked by PinkSlipped (gotpinkslipped.com/noticed/tracked/event/acumen-pharmaceuticals-inc-2026-11-05)

By the PinkSlipped teamUpdated